SYNCROSOME - Cardiovascular Preclinical expert

At a glimpse SYNCROSOME is the cardiology branch of ETAP-Lab, French preclinical CRO dedicated to in vitro & in vivo efficacy studies for pharmaceutical & biotech companies for over 30 years. Range of services SYNCROSOME is dedicated to cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension…​ Models in cardiometabolic disorders are also available. Our added value We can accelerate, derisk and support preclinical development of therapeutics thanks to relevant & translatable in vitro and in vivo models. ​Our experts aim to provide our clients with the most relevant data using state-of-the-art techniques and imaging, still to offer better predictability of compounds' efficacy. Tailored services Beyond expertise, our flexible and human-sized organization can design and operate tailored drug efficacy studies to fit client's needs.​ Check out our cardiovascular models, tailored to your HF & cardiac disease challenges in our website !